Parkview Medical Center

GE Healthcare Imaging Solutions Increase Workflow Efficiency and Optimize Radiologists’ Time to Help Reduce Burnout

Retrieved on: 
Tuesday, November 22, 2022
Technology, Nursing, Other Technology, Health Technology, Software, Other Health, Biotechnology, Hardware, General Health, Health, Workforce, Workflow, United Kingdom, Picture archiving and communication system, Operation, Complex, Health, News, Imaging, RSNA, ED, Parkview Medical Center, STAT, NYSE, Radiology, Communications system, Intervention, Quantum, WRVU, Alliance Medical, PACS, Box, Workload, GE Healthcare, Artificial intelligence, Ecosystem, AIR, Insight, SNR, TAT, Patient, Medical imaging

Imaging experts are in short supply and high demand while, at the same time, imaging is moving beyond hospital campuses.

Key Points: 
  • Imaging experts are in short supply and high demand while, at the same time, imaging is moving beyond hospital campuses.
  • GE Healthcare is focused delivering on technologies that not only help improve workflow efficiency and reduce burnout for our customers, but also provide better patient care.
  • Our customers consistently ask for fewer clicks and for actionable insights, and we design our solutions to meet those needs, said Jan Makela, President and CEO of Imaging at GE Healthcare.
  • GE Healthcare is the $17.7 billion healthcare business of GE (NYSE: GE).

Biodesix Announces New Data on Nodify Lung® Nodule Risk Assessment Testing at the CHEST 2021 Annual Meeting

Retrieved on: 
Wednesday, October 13, 2021
Oncology, Health, Clinical Trials, Research, Science, Biotechnology, Doctor of Philosophy, Biotechnology, DRS, SCLC, Degenerative disease, Population, ORACLE, PET, Annual report, Case study, Risk, Nasdaq, Chicago (franchise), Company, Behavior, Form 10-K, COVID-19, Physician, Medical College of Wisconsin, Interventional pulmonology, Autoantibody, DO, Malignancy, Internal medicine, Triage, Medical Affairs Bureau, Lung cancer, MD, Disease, Review, Medical information, Society, Diagnosis, Artificial intelligence, Critical care, Parkview Medical Center, MPH, Private Securities Litigation Reform Act, Forward-looking statement, CT, Associate, NSCLC, Lung, University, GenScript Biotech, Intelligence, Patient, Biomarker, Medical imaging, Medical device

Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company, today announced that multiple data presentations will occur at the 2021 annual CHEST virtual conference.

Key Points: 
  • Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company, today announced that multiple data presentations will occur at the 2021 annual CHEST virtual conference.
  • The prospectively collected data show the ability to reduce unnecessary invasive biopsies and surgeries, through incorporation of the Nodify XL2 test in clinical practice.
  • The author reviewed outcomes data from patients (n = 331) newly identified 8-30mm lung nodules, who were managed with Nodify XL2 testing.
  • The blood-based Nodify Lung nodule risk assessment testing strategy, consisting of the Nodify XL2 and the Nodify CDT tests, evaluates the risk of malignancy in incidental pulmonary nodules, enabling physicians to better triage patients to the most appropriate course of action.

Michael J. Wempe, MD, SC, is recognized by Continental Who's Who

Retrieved on: 
Monday, August 30, 2021
Continental, Parkview Medical Center, Pain, Anesthesia, American Board of Anesthesiology, Transplant, University, Blood pressure, Founder, University of Nebraska College of Law, Pulse, International Anesthesia Research Society, Medicine, American Board of Commissioners for Foreign Missions, Method, University of Nebraska Medical Center, Society, Interventional pain management, SC, Memorial Hospital Central, Heart, Health, University of Colorado Hospital, Learning, Private practice, Temperature, Patient, American Society of Anesthesiologists, Women's health, Colorado Medical Society, Respiration, Nebraska Medicine, American Society of Interventional Pain Physicians, Dentistry

With 35 years in practice, Michael J. Wempe, MD, SC is an experienced doctor specializing in the field of Anesthesiology and Interventional Pain Management.

Key Points: 
  • With 35 years in practice, Michael J. Wempe, MD, SC is an experienced doctor specializing in the field of Anesthesiology and Interventional Pain Management.
  • Specialties include cancer care, women's health, heart and vascular care, transplants, urgent care, and primary care.
  • In 1985, Dr. Wempe completed an internship and a residency in Anesthesiology at the University of Nebraska Medical Center.
  • Dr. Wempe has been recognized and awarded for his professional accomplishments with profile features on issuewire.com and yorkpedia.com.